# Acetazolamide Per os for Decompensation of Heart Failure

> **NCT05802849** · PHASE4 · RECRUITING · sponsor: **Samara State Medical University** · enrollment: 400 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT05802849
- **Lead sponsor:** Samara State Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2025-08-28
- **Final completion:** 2025-12-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802849, "Acetazolamide Per os for Decompensation of Heart Failure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05802849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*